This fall, tens of millions of people will be at risk for chronic traumatic encephalopathy (CTE), a degenerative brain disease caused by repeated head impacts from contact sports like football, soccer, and ice hockey, or […]
Tuberculosis, or TB, an airborne bacterial respiratory infection, is one of humanity’s oldest foes and is today the world’s leading cause of death from infectious disease, claiming more than 1.2 million lives each year. The […]
When air conditioning is not available during extreme heat, millions of older adults and other people become vulnerable to cardiac problems and other heat-related illnesses, according to researchers in the Penn State Department of Kinesiology.This […]
A multi-institutional collaboration led by the Center for Translational Cardiology and Pragmatic Randomized Trials at Copenhagen University Hospital-Herlev and Gentofte, University of Copenhagen, reports that RSVpreF vaccination reduced all-cause cardiorespiratory hospitalizations in adults aged 60 […]
As attention turns to this year’s New York City Marathon, observers will again ask a long-standing question: What do athletes draw upon when trying to complete this 26.2-mile run, especially at those stretches when finishing […]
Just as a computer’s operating system can be rewritten after a major update, dengue infection can “re-program” the body’s immune system, leaving a long-lasting genetic imprint that influences how people respond to future infections—an effect […]
As we get older, our muscle strength slowly declines—increasing our risk of falls, injuries, and loss of independence. In particular, we rely on our lower body strength for many essential daily activities such as walking […]
The type of protein you eat after intense physical training can significantly impact recovery, according to new research from Texas A&M University’s Department of Kinesiology and Sport Management.This post was originally published on this site
One shot of an RSV vaccine protects adults aged 60 or older from RSV-associated hospitalization and critical illness during two consecutive RSV seasons, according to a study published in JAMA by the IVY Network research […]
A research team has successfully developed the world’s first nasal organoid-based SARS-CoV-2 neutralizing antibody evaluation platform.This post was originally published on this site
© 2024 EarnWithSocial.ca - Canada's Technology News and Highlights | Read. Learn. Share.